269 related articles for article (PubMed ID: 17290721)
1. Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review.
Garza CA; Montori VM; McConnell JP; Somers VK; Kullo IJ; Lopez-Jimenez F
Mayo Clin Proc; 2007 Feb; 82(2):159-65. PubMed ID: 17290721
[TBL] [Abstract][Full Text] [Related]
2. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
Persson M; Hedblad B; Nelson JJ; Berglund G
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China.
Wang C; Fang X; Hua Y; Liu Y; Zhang Z; Gu X; Wu X; Tang Z; Guan S; Liu H; Liu B; Guo X; Ji X
Angiology; 2018 Jan; 69(1):49-58. PubMed ID: 28429599
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.
Garg PK; McClelland RL; Jenny NS; Criqui MH; Greenland P; Rosenson RS; Siscovick DS; Jorgensen N; Cushman M
Atherosclerosis; 2015 Jul; 241(1):176-82. PubMed ID: 26004387
[TBL] [Abstract][Full Text] [Related]
5. The association between lipoprotein-associated phospholipase A2 and cardiovascular disease and total mortality in vascular medicine patients.
Allison MA; Denenberg JO; Nelson JJ; Natarajan L; Criqui MH
J Vasc Surg; 2007 Sep; 46(3):500-6. PubMed ID: 17681710
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein-associated phospholipase A2.
McConnell JP; Hoefner DM
Clin Lab Med; 2006 Sep; 26(3):679-97, vii. PubMed ID: 16938590
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein-associated phospholipase A2 predicted cardiovascular disease in obstructive sleep apnea syndrome.
Xu C; Yu F; Mao S; Shi Y; Li Q; Fang S; Tan Y; Gu W; Ye L
Respir Med; 2020 Mar; 163():105881. PubMed ID: 32056835
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein-associated phospholipase A2 and arterial stiffness evaluation in patients with inflammatory bowel diseases.
Theocharidou E; Tellis CC; Mavroudi M; Soufleris K; Gossios TD; Giouleme O; Athyros VG; Tselepis AD; Karagiannis A
J Crohns Colitis; 2014 Sep; 8(9):936-44. PubMed ID: 24529818
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study.
Tsimikas S; Willeit J; Knoflach M; Mayr M; Egger G; Notdurfter M; Witztum JL; Wiedermann CJ; Xu Q; Kiechl S
Eur Heart J; 2009 Jan; 30(1):107-15. PubMed ID: 19019993
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein-Associated Phospholipase A2 and Incident Peripheral Arterial Disease in Older Adults: The Cardiovascular Health Study.
Garg PK; Arnold AM; Hinckley Stukovsky KD; Koro C; Jenny NS; Mukamal KJ; Criqui MH; Furberg CD; Newman AB; Cushman M
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):750-6. PubMed ID: 26848158
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection.
Ross Eckard A; Longenecker CT; Jiang Y; Debanne SM; Labbato D; Storer N; McComsey GA
HIV Med; 2014 Oct; 15(9):537-46. PubMed ID: 24650269
[TBL] [Abstract][Full Text] [Related]
12. [Lipoprotein-associated phospholipase A2 serum levels in patients from different categories of cardiovascular risk].
Nozadze DN; Sergienko IV; Balakhonova TV; Semenova AE; Vlasik TN; Kukharchuk VV
Kardiologiia; 2014; 54(3):57-63. PubMed ID: 25102750
[TBL] [Abstract][Full Text] [Related]
13. Possible effects of lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms on cardiovascular risk in patients with preeclampsia.
Güngör ZB; Tüten A; Ekmekçi H; Ekmekçi ÖB; Kucur M; Öncül M; Donma O; Madazlı R; Sönmez H
J Matern Fetal Neonatal Med; 2018 Dec; 31(23):3119-3127. PubMed ID: 28784006
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature.
Madjid M; Ali M; Willerson JT
Tex Heart Inst J; 2010; 37(1):25-39. PubMed ID: 20200624
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein-associated phospholipase A2, vascular inflammation and cardiovascular risk prediction.
Sudhir K
Vasc Health Risk Manag; 2006; 2(2):153-6. PubMed ID: 17319459
[TBL] [Abstract][Full Text] [Related]
16. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein-associated phospholipase A
Garg PK; Jorgensen NW; McClelland RL; Jenny NS; Criqui MH; Allison MA; Greenland P; Rosenson RS; Siscovick DS; Cushman M
Vasc Med; 2017 Feb; 22(1):5-12. PubMed ID: 28215109
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress.
Koenig W; Twardella D; Brenner H; Rothenbacher D
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1586-93. PubMed ID: 16627803
[TBL] [Abstract][Full Text] [Related]
19. Elevated circulating levels of lipoprotein-associated phospholipase A2 in obese children.
Sakka S; Siahanidou T; Voyatzis C; Pervanidou P; Kaminioti C; Lazopoulou N; Kanaka-Gantenbein C; Chrousos GP; Papassotiriou I
Clin Chem Lab Med; 2015 Jun; 53(7):1119-25. PubMed ID: 25581763
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target.
Carlquist JF; Muhlestein JB; Anderson JL
Expert Rev Mol Diagn; 2007 Sep; 7(5):511-7. PubMed ID: 17892360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
